The Pacific Journal of Oncology & Immunotherapy (PJOI) is a leading international, open-access, peer-reviewed journal dedicated to advancing research in oncology and immunotherapy. The journal aims to provide a platform for the dissemination of cutting-edge scientific research, clinical studies, and reviews that contribute to the ongoing progress in cancer treatment and immune-based therapies. PJOI seeks to foster collaboration among researchers, clinicians, and healthcare professionals to improve cancer care globally.

 

Scope

PJOI covers a broad range of topics within oncology and immunotherapy, addressing both foundational concepts and emerging innovations. The journal invites submissions that explore diverse areas impacting cancer treatment and patient outcomes:

• Cancer Biology: Understanding molecular mechanisms, tumor

progression, and metastasis.

• Immune Checkpoint Inhibitors: Research on checkpoint inhibitors and their clinical applications.
• CAR-T Cell Therapy: Studies on chimeric antigen receptor T-cell therapies.
• Cancer Vaccines: Investigating the development and clinical use of vaccines for cancer prevention and treatment.
• Monoclonal Antibodies: Research on monoclonal antibody therapies in oncology.
• Combination Therapies: Integrating immunotherapy with chemotherapy, radiotherapy, and surgery.
• Tumor Microenvironment: Understanding tumor-host interactions and immune evasion.
• Cancer Genomics: Exploring the genetic landscape of cancer and its implications for personalized therapy.
• Immune System Modulation: Investigating strategies to enhance the immune system’s ability to fight cancer.
• Tumor Immune Evasion: Research on how tumors escape immune surveillance.
• Clinical Trials: Outcomes of immunotherapy clinical trials and innovative treatment protocols.
• Personalized Oncology: Approaches to tailoring cancer treatments based on genetic and molecular profiling.
• Biomarkers: Identification and validation of biomarkers for cancer diagnosis, prognosis, and treatment.
• Translational Research: Bridging laboratory findings with clinical applications.
• Cancer Immunology: Immune system interactions with cancer cells and immune response.
• Epidemiology: Population-based studies on cancer prevalence, risk factors, and survival.
• Cancer Prevention: Research on prevention strategies and early detection methods.
• Pharmacology: Research on drug development, pharmacokinetics, and therapeutic applications in oncology.
• Therapeutic Resistance: Exploring mechanisms of resistance to cancer therapies and potential solutions.
• Adverse Effects of Immunotherapy: Investigating the side effects and management of immune-based therapies.
• Regulatory Approaches: Understanding global regulations related to cancer treatments and immunotherapies.
• Emerging Technologies: Innovations in cancer treatment technologies and delivery systems.
• Health Policy: Analysis of policies affecting cancer treatment access and outcomes.
• Global Cancer Research: International perspectives and collaborations in cancer care and research.
• Cancer Survivorship: Exploring the long-term effects of cancer treatment on patients' quality of life.
• Integrative Oncology: Exploring the combination of conventional and alternative therapies in cancer treatment.
• Patient Advocacy: Research on improving patient-centered care and advocating for better cancer care practices.
• Cancer Immunotherapy Innovations: Cutting-edge therapies and advancements in immune modulation.
• Cancer Treatment Optimization: Methods to enhance the efficacy of existing cancer treatments.
• Palliative Care: Research on managing symptoms and improving the quality of life for advanced cancer patients.

 

PJOI strives to publish high-quality, peer-reviewed articles that provide valuable insights into the evolving landscape of cancer research and treatment, aiming to make a tangible impact on global cancer care and patient outcomes.